UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 661

Sortiert nach

Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis

The Lancet. Psychiatry, 2014-10, Vol.1 (5), p.368-376

2014

Link zum Volltext

Verfügbarkeit prüfen

Toward fulfilling the aspirational goal of science as self‐correcting: A call for editorial courage and diligence for error correction

European journal of clinical investigation, 2020-02, Vol.50 (2), p.e13190-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension

Trials, 2018-07, Vol.19 (1), p.407-407, Article 407

2018

Link zum Volltext

Verfügbarkeit prüfen

CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials

Trials, 2018-07, Vol.19 (1), p.406-406, Article 406

2018

Link zum Volltext

Verfügbarkeit prüfen

Toward more rigorous and informative nutritional epidemiology: The rational space between dismissal and defense of the status quo

Critical reviews in food science and nutrition, 2023, Vol.63 (18), p.3150-3167

2023

Link zum Volltext

Verfügbarkeit prüfen

Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events

Trials, 2019-09, Vol.20 (1), p.553-553, Article 553

2019

Link zum Volltext

Verfügbarkeit prüfen

Caveat emptor: the combined effects of multiplicity and selective reporting

Trials, 2018-09, Vol.19 (1), p.497-497, Article 497

2018

Link zum Volltext

Verfügbarkeit prüfen

New guidelines are needed to improve the reporting of trials in addiction sciences

Addiction (Abingdon, England), 2013-09, Vol.108 (9), p.1687-1688

2013

Link zum Volltext

Verfügbarkeit prüfen

Development of a CONSORT extension for interventions in public health and related disciplines

The Lancet (British edition), 2012, Vol.380, p.S14-S14

2012

Link zum Volltext

Verfügbarkeit prüfen

Summaries of harms in systematic reviews are unreliable Paper 1: An introduction to research on harms

Journal of clinical epidemiology, 2021-11, Vol.143, p.186-196

2021

Link zum Volltext

Verfügbarkeit prüfen

Are manufacturers sharing data as promised?

BMJ (Online), 2015-09, Vol.351, p.h4169

2015

Link zum Volltext

Verfügbarkeit prüfen

Can non-pharmacological interventions prevent relapse in adults who have recovered from depression? A systematic review and meta-analysis of randomised controlled trials

Clinical psychology review, 2015-07, Vol.39, p.58-70

2015

Link zum Volltext

Verfügbarkeit prüfen

Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 years of age

Journal of evidence-based medicine, 2011-05, Vol.4 (2), p.141-141

2011

Link zum Volltext

Verfügbarkeit prüfen

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Journal of clinical epidemiology, 2021-06, Vol.134, p.178-189

2021

Link zum Volltext

Verfügbarkeit prüfen

Harms in Systematic Reviews Paper 3: Given the same data sources, systematic reviews of gabapentin have different results for harms

Journal of clinical epidemiology, 2022-03, Vol.143, p.224-241

2022

Link zum Volltext

Verfügbarkeit prüfen

Apparent discrepancy between published study of gabapentin treatment and internal company report

The journal of clinical psychiatry, 2013-08, Vol.74 (8), p.853

Mayo-Wilson, Evan

2013

Link zum Volltext

Verfügbarkeit prüfen

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials

BMJ (Online), 2023-04, Vol.381, p.e073725

2023

Link zum Volltext

Verfügbarkeit prüfen

Can electronic monitoring reduce crime for moderate to high-risk offenders?

Journal of experimental criminology, 2005-07, Vol.1 (2), p.215-237

2005

Link zum Volltext

Verfügbarkeit prüfen

NICE guidance: why not clozapine for treatment-refractory bipolar disorder? – Authors' reply

The Lancet. Psychiatry, 2016-06, Vol.3 (6), p.503-503

2016

Link zum Volltext

Verfügbarkeit prüfen

Correspondence

Psychological medicine, 2007-08, Vol.37 (8), p.1211-1212

MAYO-WILSON, EVAN

2007

Link zum Volltext

Verfügbarkeit prüfen

Designing clinically useful psychopharmacological trials: challenges and ways forward

The Lancet. Psychiatry, 2022-07, Vol.9 (7), p.584-594

2022

Link zum Volltext

Verfügbarkeit prüfen

Time From Submission of Johns Hopkins University Trial Results to Posting on ClinicalTrials.gov

JAMA internal medicine, 2020-02, Vol.180 (2), p.317

2020

Link zum Volltext

Verfügbarkeit prüfen

Data management in substance use disorder treatment research: Implications from data harmonization of National Institute on Drug Abuse-funded randomized controlled trials

Clinical trials (London, England), 2021-04, Vol.18 (2), p.215-225

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 661

Suche als RSS-Feed

Aktive Filter

KollektionApplied Social Sciences Index & Abstracts (ASSIA)

KollektionFree E-Journal (出版社公開部分のみ）

SpracheNorwegisch

ThemaPublic, Environmental & Occupational Health

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(591)
Mit Volltextzugriff
(581)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(17)
... seit 90 Tagen
(52)

Menü

Weitere Dienste

Einstellungen

Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis

Toward fulfilling the aspirational goal of science as self‐correcting: A call for editorial courage and diligence for error correction

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews

Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension

CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials

Toward more rigorous and informative nutritional epidemiology: The rational space between dismissal and defense of the status quo

Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events

Caveat emptor: the combined effects of multiplicity and selective reporting

New guidelines are needed to improve the reporting of trials in addiction sciences

Development of a CONSORT extension for interventions in public health and related disciplines

Summaries of harms in systematic reviews are unreliable Paper 1: An introduction to research on harms

Are manufacturers sharing data as promised?

Can non-pharmacological interventions prevent relapse in adults who have recovered from depression? A systematic review and meta-analysis of randomised controlled trials

Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 years of age

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Harms in Systematic Reviews Paper 3: Given the same data sources, systematic reviews of gabapentin have different results for harms

Apparent discrepancy between published study of gabapentin treatment and internal company report

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials

Can electronic monitoring reduce crime for moderate to high-risk offenders?

NICE guidance: why not clozapine for treatment-refractory bipolar disorder? – Authors' reply

Correspondence

Designing clinically useful psychopharmacological trials: challenges and ways forward

Time From Submission of Johns Hopkins University Trial Results to Posting on ClinicalTrials.gov

Data management in substance use disorder treatment research: Implications from data harmonization of National Institute on Drug Abuse-funded randomized controlled trials

Aktive Filter

Suchergebnisse filtern